# A Blood Collection Study to Assess the Immunogenicity of Nationally Authorized Homologous COVID-19 Booster Vaccines Among Adult Vaccinees.

> **NCT05710289** · — · WITHDRAWN · sponsor: **SK Bioscience Co., Ltd.**

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** Immune Responses

## Key facts

- **NCT ID:** NCT05710289
- **Lead sponsor:** SK Bioscience Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-02
- **Primary completion:** 2024-02
- **Final completion:** 2024-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor's decision
- **Last updated:** 2023-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05710289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05710289, "A Blood Collection Study to Assess the Immunogenicity of Nationally Authorized Homologous COVID-19 Booster Vaccines Among Adult Vaccinees.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05710289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*